Skip to contentCHAMPSI FARAH — Kite Pharma, Inc. insider: 99 transactions · InsiderLensCHAMPSI FARAH
- 10% owner at THRESHOLD PHARMACEUTICALS INC · on record since Sep 5, 2008
- 10% owner at AXONYX INC · on record since Oct 5, 2006
- Nolonger 10% Owner at COTHERIX INC · on record since Jan 9, 2007
- 10% owner at NeurogesX Inc · on record since May 8, 2007
- 10% owner at CORCEPT THERAPEUTICS INC · on record since Aug 20, 2007
- 10% owner at ATS MEDICAL INC · on record since Jul 2, 2007
- 10% owner at CORGENTECH INC · on record since Dec 19, 2007
- 10% owner at SUNESIS PHARMACEUTICALS INC · on record since Apr 7, 2009
- No longer 10% owner at AXONYX INC · on record since Sep 8, 2009
- Former 10% owner at THRESHOLD PHARMACEUTICALS INC · on record since Oct 6, 2009
- Former 10% Owner at SUNESIS PHARMACEUTICALS INC · on record since Jul 2, 2010
- 10% owner at Aegerion Pharmaceuticals, Inc. · on record since Oct 27, 2010
- 10% owner at Cara Therapeutics, Inc. · on record since Jan 30, 2014
- Director at ORPHAN MEDICAL INC · on record since Jun 25, 2004
- Director at PORTOLA PHARMACEUTICALS INC · on record since May 30, 2013
- 10% owner at Esperion Therapeutics, Inc. · on record since Jun 25, 2013
- Director at Comtrix, Inc. · on record since Apr 16, 2013
- 10% owner at Comtrix, Inc. · on record since Apr 10, 2013
- Director at TREVENA INC · on record since Jan 30, 2014
- 10% owner at TREVENA INC · on record since Jan 30, 2014
- 10% owner at APPLIED GENETIC TECHNOLOGIES CORP · on record since Mar 26, 2014
- Director at RENOVIS INC · on record since Feb 4, 2004
- 10% owner at RENOVIS INC · on record since Feb 4, 2004
- Director at Kite Pharma, Inc. · on record since Jun 27, 2014
- 10% owner at ZS Pharma, Inc. · on record since Jun 25, 2014
- 10% owner at SCYNEXIS INC · on record since May 8, 2014
- 10% owner at Immune Design Corp. · on record since Jul 31, 2014
- See footnotes at RIGEL PHARMACEUTICALS INC · on record since Feb 23, 2004
- 10% owner at Neothetics, Inc. · on record since Nov 25, 2014
- 10% owner at COTHERIX INC · on record since Oct 15, 2004
- 10% owner at Lifeline Systems, Inc. · on record since May 14, 2015
- Former 10% Owner at Neothetics, Inc. · on record since Dec 30, 2015
- 10% owner at SUTRO BIOPHARMA, INC. · on record since Sep 26, 2018
- 10% owner at Allakos Inc. · on record since Jul 23, 2018
- Director at PHC INC /MA/ · on record since Nov 17, 2020
- No longer a Director at RENOVIS INC · on record since Aug 9, 2005
- 10% owner at INTARCIA THERAPEUTICS, INC · on record since Sep 20, 2005
Insider trading activity of CHAMPSI FARAH
- Transactions on record
- 99
- since Feb 11, 2004
- Open-market buys
- 7
- $3.4M
- Open-market sells
- 17
- $71.5M
- Companies traded
- 12
- last filing Jan 26, 2021
Figures computed from official regulatory filings — methodology.
Companies where CHAMPSI FARAH has traded
- PHC INC /MA/1 tx · $10.8M · Jan 26, 2021
- Allakos Inc.7 tx · Jan 24, 2020
- Kite Pharma, Inc.31 tx · $99.1M · Oct 5, 2017
- Lifeline Systems, Inc.7 tx · May 14, 2015
- TREVENA INC1 tx · May 15, 2014
- Comtrix, Inc.7 tx · $6.9M · Oct 23, 2013
- Esperion Therapeutics, Inc.5 tx · $3.3M · Jul 1, 2013
- PORTOLA PHARMACEUTICALS INC12 tx · May 30, 2013
- Aegerion Pharmaceuticals, Inc.6 tx · $120.7K · Aug 9, 2011
- NeurogesX Inc
Track record of CHAMPSI FARAH
Statistical track record
Free- Open-market buys
- 7
- Last buy
- Jul 1, 2013
Win rates and median returns are available with a free account (5 insiders/month).
Create a free account→Transaction history of CHAMPSI FARAH
Co-insiders of CHAMPSI FARAH
This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →
5 tx · May 8, 2007
ALTA BIOPHARMA PARTNERS III LPAegerion Pharmaceuticals, Inc. +7
| Company | Filed | Type | Qty | Price | Value · USD | Src |
|---|
| Jan 26, 2021 | OtherD | 43,125 | 250.00 USD | $10.8M | SEC |
| Jan 24, 2020 | Other | 11,539 | 0.00 USD | $0 | SEC |
| Jan 24, 2020 | Other | -1,000,000 | 0.00 USD | $0 | SEC |
| Jan 24, 2020 | Other | 11,538 | 0.00 USD | $0 | SEC |
| Jan 24, 2020 | Other | 11,538 | 0.00 USD | $0 | SEC |
| Jan 24, 2020 | Other | -34,615 | 0.00 USD | $0 | SEC |
| Jan 24, 2020 | Other | 34,615 | 0.00 USD | $0 | SEC |
| Jan 24, 2020 | Other | 6,837 | 0.00 USD | $0 | SEC |
| Oct 5, 2017 | OtherD | -50,000 | 178.65 USD | $8.9M | SEC |
| Oct 5, 2017 | Gift | -2,800 | 0.00 USD | $0 | SEC |
| Oct 5, 2017 | Other | -1,807 | — | — | SEC |
| Oct 5, 2017 | OtherD | -8,810 | 88.79 USD | $782.2K | SEC |
| Oct 5, 2017 | Other | -61,467 | 180.00 USD | $11.1M | SEC |
| Oct 5, 2017 | OtherD | -7,000 | 129.13 USD | $903.9K | SEC |
| Oct 5, 2017 | OtherD | -10,000 | 120.77 USD | $1.2M | SEC |
| Jun 22, 2017 | Award | 2,410 | 0.00 USD | $0 | SEC |
| Jun 22, 2017 | AwardD | 8,810 | 0.00 USD | $0 | SEC |
| Jun 16, 2017 | Sell | -15,000 | 90.40 USD | $1.4M | SEC |
| Jun 16, 2017 | Sell | -5,450 | 88.11 USD | $480.2K | SEC |
| May 1, 2017 | Sell | -2,617 | 82.59 USD | $216.1K | SEC |
| May 1, 2017 | Sell | -16,551 | 82.77 USD | $1.4M | SEC |
| Apr 26, 2017 | Sell | -200 | 83.06 USD | $16.6K | SEC |
| Apr 26, 2017 | Sell | -51,112 | 82.72 USD | $4.2M | SEC |
| Apr 26, 2017 | Sell | -25,818 | 82.34 USD | $2.1M | SEC |
| Apr 26, 2017 | Sell | -15,316 | 83.29 USD | $1.3M | SEC |